Skip to main content

FDA advisors recommend BioNTech and Pfizer’s COVID-19 shot for children

A group of scientists who advise the Food and Drug Administration said the benefits of BioNTech and Pfizer's COVID-19 vaccine outweigh the risks for children between the ages of 5 and 11.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.